Status:
ACTIVE_NOT_RECRUITING
Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults
Lead Sponsor:
UConn Health
Collaborating Sponsors:
Oregon Social Learning Center
University of Texas at Austin
Conditions:
Substance Use Disorders
Eligibility:
All Genders
18-25 years
Phase:
NA
Brief Summary
Emerging adults (ages 18-25) are at higher risk for substance use disorders, including opiate addiction, than any other age group but are also more likely to drop out early from substance use treatmen...
Detailed Description
Emerging adults (EAs; ages 18-25) have higher rates of substance use disorders than any other age group and have been hit particularly hard by the opioid crisis. EAs also demonstrate poor adherence to...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- 18-25
- initiating outpatient treatment for a substance use problem
Exclusion
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2027
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT05374395
Start Date
July 1 2023
End Date
February 28 2027
Last Update
January 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UConn Health
Farmington, Connecticut, United States, 06030